Cytosorbents (CTSO) vs Femasys (FEMY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cytosorbents (CTSO) has outperformed Femasys (FEMY) over the past year, losing 80.9% versus a loss of 86.6%. Over five years, CTSO leads with a -96.8% price change compared with -98.6% for FEMY. Femasys is the larger company by market cap ($17.1 million vs $11.8 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTSO | FEMY |
|---|---|---|
| Share price | $3.73 | $2.05 |
| Market cap | $11.75M | $17.13M |
| 1-day change | -3.62% | +2.25% |
| YTD return | -70.81% | -82.64% |
| 1-year return | -80.87% | -86.61% |
| 5-year return | -96.82% | -98.57% |
| EPS (TTM) | $-5.80 | $-3.28 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $20.00 | $22.20 |
| 52-week low | $3.66 | $1.94 |
| Distance from 52-week high | -81.35% | -90.79% |
| Average volume | 12.33K | 721.18K |
| Shares outstanding | 3.15M | 8.38M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CTSO vs FEMY FAQ
Which is bigger, Cytosorbents or Femasys?
Femasys (FEMY) is larger, with a market capitalization of $17.13M compared with $11.75M for Cytosorbents (CTSO).
Which stock has performed better over the past year, CTSO or FEMY?
CTSO returned -80.87% over the past 12 months, compared with -86.61% for FEMY (price return, excluding dividends). Past performance does not predict future results.
Are Cytosorbents and Femasys in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.